Submitted by Anonymous (not verified) on 28 April 2026 - 16:28
Human medicines European public assessment report (EPAR): Neuraceq, florbetaben (18F), Date of authorisation: 20/02/2014, Revision: 27, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Neuraceq, florbetaben (18F), Date of authorisation: 20/02/2014, Revision: 27, Status: Authorised